NDC 51004-1097
Scandonest L
Mepivacaine Hydrochloride And Levonordefrin
Scandonest L is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novocol Pharmaceutical Of Canada, Inc. The primary component is Mepivacaine Hydrochloride; Levonordefrin.
Product ID | 51004-1097_59fcd689-a6a3-4739-a982-6b41c249de7b |
NDC | 51004-1097 |
Product Type | Human Prescription Drug |
Proprietary Name | Scandonest L |
Generic Name | Mepivacaine Hydrochloride And Levonordefrin |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2013-06-27 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA088388 |
Labeler Name | Novocol Pharmaceutical of Canada, Inc |
Substance Name | MEPIVACAINE HYDROCHLORIDE; LEVONORDEFRIN |
Active Ingredient Strength | 20 mg/mL; mg/mL |
Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |